“Comparison of efficacy and safety of topical hydroquinone 2% and oral tranexamic acid 500 mg in patients of melasma”, J Pak Assoc Dermatol, vol. 27, no. 3, pp. 204–213, Mar. 2018, doi: 10.66344/jpad.v27i3.1112.